Application segmentation of the Radial Artery Compression Device market distinguishes three primary use‑cases: Diagnostic procedures, Interventional cardiology, and Peripheral interventions. Diagnostic procedures, accounting for roughly 40 % of total sales, involve post‑catheterization hemostasis after coronary angiography, where rapid, reliable compression reduces vascular complications and shortens patient discharge time. Interventional cardiology, representing about 35 % of the market, includes percutaneous coronary interventions (PCI) and structural heart device implantations; these procedures demand higher compression pressures and longer dwell times, driving demand for devices with adjustable tension mechanisms. Peripheral interventions, contributing the remaining 25 %, cover radial access for peripheral arterial disease treatments and upper‑extremity endovascular therapies, where device selection is influenced by vessel size variability and operator preference. Collectively, these application categories shape the overall market size, and the proportional distribution is reflected in the accompanying pie‑chart. This Radial Artery Compression Device segmentation analysis underscores the relative revenue impact of each clinical scenario. These figures also inform manufacturers' product‑development priorities and pricing strategies.
